Company profile
Imperial Bioscience Ltd is a UK company with status active founded in 2016 based in London.
Financial period: 1 Feb 2024 to 31 Jan 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQ0MTA4ODAyOGFkaXF6a2N4
Published 28 Oct 2024 10:02
CS01 | Transaction MzQzNjgxMjUzOGFkaXF6a2N4
Published 23 Sep 2024 09:19
Company registered at Companies House
1 May 2023 to 30 Apr 2025
Imperial Bioscience aims to be the first-to-market with their microneedle drug delivery product for medical use. Microneedle-mediated delivery is defined as the non-invasive delivery of medications through the skin surface. This is an alternative to hypodermic needles, which provides enhanced patient compliance. Expanded microneedle patch technology will ...
